<?xml version="1.0" encoding="UTF-8"?>
<p>Autologous stem cell transplantation (ASCT) is the standard of care for newly diagnosed multiple myeloma (MM) patients determined able to withstand high‐dose chemotherapy.
 <xref rid="cam41690-bib-0001" ref-type="ref">1</xref> ASCT hospitalization is associated with high levels of both clinically diagnosed depression and self‐reported depressive symptoms. This depression rises rapidly within the first week of hospitalization.
 <xref rid="cam41690-bib-0002" ref-type="ref">2</xref>, 
 <xref rid="cam41690-bib-0003" ref-type="ref">3</xref>, 
 <xref rid="cam41690-bib-0004" ref-type="ref">4</xref> One study found that while 7.8% of patients were clinically depressed during the week preceding hospitalization, 36.7% of patients were clinically depressed by day eight of hospitalization.
 <xref rid="cam41690-bib-0004" ref-type="ref">4</xref>
</p>
